Germline genetic contribution to the immune landscape of cancer.

Journal: Immunity

Published: 2021-02-09

DOI: 10.1016/j.immuni.2021.01.011

Affiliations: 31

Authors: 26

Go to article
Institutions Share
University of California, San Francisco (UCSF), United States of America (USA) 0.19
Sidra Medical and Research Center, Qatar 0.08
Institute for Systems Biology (ISB), United States of America (USA) 0.08
University of Calgary (U of C), Canada 0.05
UCSF Health, United States of America (USA) 0.05
Hamad Bin Khalifa University (HBKU), Qatar 0.04
Arnie Charbonneau Cancer Institute, Canada 0.04
Refuge Biotechnologies Inc., United States of America (USA) 0.04
Leukemia Therapeutics, LLC, United States of America (USA) 0.04
Ontario Institute for Cancer Research (OICR), Canada 0.04
NYU Langone Health, United States of America (USA) 0.04
The University of Chicago (UChicago), United States of America (USA) 0.04
Lebanese University (LU), Lebanon 0.02
University of Sannio, Italy 0.02
University of Naples Federico II (UNINA), Italy 0.02
Qatar Computing Research Institute (QCRI), HBKU, Qatar 0.02
Josep Carreras Leukaemia Research Institute (IJC), Spain 0.02
Biology and Molecular Genetics (Biogem), Italy 0.02
Barcelona Supercomputing Center (BSC), Spain 0.02
Leiden University Medical Center (LUMC), Netherlands 0.02
Laboratory of Integrative Cancer Immunology (ICI), France 0.02
Ligue Contre Le Cancer, France 0.02
Beckman Research Institute, City of Hope, United States of America (USA) 0.01
Lawrence Berkeley National Laboratory (LBNL), United States of America (USA) 0.01
University of Genova, Italy 0.01
Weill Cornell Medicine-Qatar (WCM-Q), Cornell University, Qatar 0.01
Stanford University, United States of America (USA) 0.01
Tenaya Therapeutics, United States of America (USA) 0.01

Return